Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism: Cochrane systematic review

Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central